Understanding COVID-19 is our best defense to protect against it. The Centers for Disease Control and
Prevention, as well as many agencies and institutions around the world have joined ranks, conducting
thousands upon thousands of studies in the fight against COVID-19. The extensive COVID-19 research,
including epidemiological studies, cohort studies and serology studies, has ramped up across our
country and throughout the world.
Learning more about COVID-19 and the virus that causes it is where epidemiological studies come into
play. With epidemiology studies, we can attempt to determine the source of the outbreak, its path and
the extent of havoc it wreaks.
Epidemiology studies are useful in the determination of the incubation period – the actual time from the
point of exposure until a person suffers from symptoms. What epidemiologists have already uncovered
is that a person can be infected with COVID-19 for 2 to 14 days before they experience symptoms or
they may never experience symptoms at all.
Epidemiology is also useful for determining how long it will take before an individual infected with
COVID-19 is rid of the virus. Current recommendations from the CDC for those infected by COVID-19
include self-isolation until they have gone at least three days without a fever, any other symptoms have
ceased, as well as ten days after any symptoms appeared.
The range of symptoms and the severity of those symptoms can also be uncovered through
epidemiology testing and are extremely beneficial in the diagnosis and treatment of diseases including
COVID-19. It also helps discover risk factors. For example, we now know that older individuals and those
with underlying medical conditions are at higher risk for developing severe symptoms should they
become infected with COVID-19. Finally, morbidity and mortality can be determined through
epidemiology research. Finding out how often COVID-19 causes illness and death helps us better
understand the impact of this terrible disease.
Then, through cohort studies – the studies that track groups of individuals over a period of time – we
can learn a great deal of beneficial information, helping public health professionals to best prioritize
prevention and treatment strategies for those who may be at the greatest risk. For instance, recent
cohort research has indicated that African Americans tend to be at greater risk of suffering from severe
COVID-19 symptoms. Once information like this is collected, funds and testing can be dispersed
appropriately to help slow the spread of the virus among the individuals that are found to be at greater
Current COVID-19 cohort studies are delving into and tracking the severity of this illness and risk factors
associated with its severity, the manner in which this illness affects specific populations, and use of
healthcare and medicines for the purpose of infection prevention, treatment and control of COVID-19.
Valuable research is also being conducted through serology studies – those tests used to detect COVID-
19 antibodies. This type of testing is extremely valuable because individuals who may have been
infected by COVID-19 may develop proteins in the blood that can fight the virus. Also, by determining
how many people actually possess antibodies within their system, researchers can help to verify how
much a virus – like COVID-19 – has spread within a population.
Current serology studies include large scale geographic surveys, surveys within certain communities and
surveys focusing on specific populations. They can help us reveal exactly how COVID-19 infections
progress through our populations, communities and geographic areas and thereby help us take the best
steps as it relates to protection against and treatment of COVID-19.
COVID-19 is an insidious virus unique to anything we have seen and experienced before. Just one
example of what makes it so difficult to stop is the fact that most of the people infected with COVID-19
don’t even know that they have it and the potential to spread it exponentially. Case in point: According
to the Centers for Disease Control and Prevention, 238 young adult United States service members
aboard a naval aircraft tested positive for COVID-19 or for a previous infection of COVID-19. Only one in
five of those tested reported any symptoms.
From protecting the health and lives of our children, their grandparents and everyone in between; to
building back our economy and livelihoods; to effectively opening schools and colleges; and attending
sporting events and concerts in person; the future of our nation…and our world depend upon the
research it will take to defend against COVID-19.
Riverside Clinical Research is in the process of preparing research studies related to COVID-19. If you are
interested joining the fight against COVID-19 by taking part in a clinical research study, please feel free
to call Riverside Clinical Research for more information at 386-428-7730 Monday through Thursday from
7 a.m. to 5 p.m. or Friday from 7 a.m. to 12 p.m.; or email your questions to
firstname.lastname@example.org. You can also learn more about the current clinical research trials at
Riverside Clinical Research by accessing our patient portal which can be found on our website. Thank
you for your interest in the betterment of healthcare.
An award-winning research facility, Riverside Clinical Research, has earned an unparalleled reputation
for clinical research trial trendsetting. The doctors and experienced research professionals at the
Riverside Clinical Research facility work in tandem with clinical trial volunteers to discover and develop
innovations in healthcare. One of the best medical research facilities in this entire area, Riverside Clinical
Research, conveniently located at 1410 S. Ridgewood Avenue in Edgewater, is equipped to support up
to 26 in-house patients as well as a large number of outpatients.